http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20200099901-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_80cbc9fc3a4bde51deab18978496c91b |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1647 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0021 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58 |
| filingDate | 2019-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_367b7ecf53d47c43692df4c225f79968 |
| publicationDate | 2020-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20200099901-A |
| titleOfInvention | Subcutaneous injection composition containing microparticles comprising finasteride |
| abstract | The present invention is a composition for subcutaneous injection containing microparticles comprising finasteride, microparticles comprising finasteride and a biodegradable polymer; And a suspension solvent. According to the composition for subcutaneous injection of the present invention, it is provided in a dosage form capable of subcutaneous injection rather than an oral dosage form, so there is no need for storage by the user, and the effect of treating hair loss by finasteride can be exhibited through a method of direct administration at a hospital. Excellent storage and ease of handling. When microparticles containing finasteride are administered using the composition for subcutaneous injection of the present invention, the effect of long-term drug administration can be maintained for a period of 1 to 3 months. In addition, the present invention controls the release of the drug from the microparticles to maintain a constant effective drug concentration, as the diameter of the particles is manufactured to a size of a constant micro size, and is applied to injections composed of particles of a uniform size. As a result, it can be provided as an injectable composition that reduces foreign body sensation and pain when administered as an injection to a patient. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11484495-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113081959-A |
| priorityDate | 2019-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 71.